Zimmer Biomet Holdings, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
Zimmer Biomet's 2024 results show a net sales increase of 3.8% and the company plans to acquire Paragon 28, Inc.
NYSE
Zimmer Biomet has updated its executive change in control severance agreements to provide for either a reduction in payments to avoid excise tax or full payment, whichever results in a better after-tax outcome for the executive.